OBJECTIVES: The number of HIV-infected refugees entering the USA is increasing. There is little data describing the HIV-infected refugee population and the challenges encountered when caring for them. We performed a retrospective case-control analysis of HIV-infected refugees in order to characterize their co-morbidities, baseline HIV characteristics, and longitudinal care compared to HIV-infected non-refugees. METHODS: A retrospective chart review was performed of HIV-infected refugees and non-refugees who were matched for gender, age, and time of establishment of initial HIV care. RESULTS: The refugee population studied was largely from West Africa. Refugees were more likely than non-refugees to have heterosexual risk for HIV infection, latent tuberculosis infection, and active hepatitis B. Refugees were less likely than non-refugees to have a history of substance use, start antiretrovirals, and be enrolled in a clinical study. The baseline CD4 counts and HIV plasma viral loads were similar between the two groups. CONCLUSIONS: Clinicians caring for West African HIV-infected refugees should be knowledgeable about likely co-morbidities and the impact of cultural differences on HIV care. Further studies are needed to develop culturally competent HIV treatment, education, and prevention programs for refugees who are beginning a new life in the USA.
OBJECTIVES: The number of HIV-infected refugees entering the USA is increasing. There is little data describing the HIV-infected refugee population and the challenges encountered when caring for them. We performed a retrospective case-control analysis of HIV-infected refugees in order to characterize their co-morbidities, baseline HIV characteristics, and longitudinal care compared to HIV-infected non-refugees. METHODS: A retrospective chart review was performed of HIV-infected refugees and non-refugees who were matched for gender, age, and time of establishment of initial HIV care. RESULTS: The refugee population studied was largely from West Africa. Refugees were more likely than non-refugees to have heterosexual risk for HIV infection, latent tuberculosis infection, and active hepatitis B. Refugees were less likely than non-refugees to have a history of substance use, start antiretrovirals, and be enrolled in a clinical study. The baseline CD4 counts and HIV plasma viral loads were similar between the two groups. CONCLUSIONS: Clinicians caring for West African HIV-infected refugees should be knowledgeable about likely co-morbidities and the impact of cultural differences on HIV care. Further studies are needed to develop culturally competent HIV treatment, education, and prevention programs for refugees who are beginning a new life in the USA.
Authors: Bethany Young Holt; Paul Effler; William Brady; Jennifer Friday; Ermias Belay; Kathleen Parker; Michael Toole Journal: Disasters Date: 2003-03
Authors: Omobosola O Akinsete; Tracy Sides; Diane Hirigoyen; Charles Cartwright; Christy Boraas; Cynthia Davey; Luisa Pessoa-Brandão; Mary McLaughlin; Ellen Kane; Jane Hall; Keith Henry Journal: AIDS Patient Care STDS Date: 2007-05 Impact factor: 5.078
Authors: Susanna E Winston; Brian T Montague; Michael J Lopez; Allison Delong; Chloe Lemarchand; Armando Bedoya; Fizza S Gillani; Curt G Beckwith Journal: J Int Assoc Provid AIDS Care Date: 2012-09-28
Authors: Sara A Lowther; Glenise Johnson; Brett Hendel-Paterson; Kailey Nelson; Blain Mamo; Kristina Krohn; Luisa Pessoa-Brandão; Ann O'Fallon; William Stauffer Journal: Int J Environ Res Public Health Date: 2012-11-16 Impact factor: 3.390